Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Tyrosine-protein phosphatase non-receptor type 4 (PTPN4) is a member of the protein tyrosine phosphatase family, acting as a signaling molecule regulating cell growth, differentiation, cell cycle, and transformation[1][4]. It has a C-terminal phosphatase domain and an N-terminal region related to the band 4.1 superfamily, suggesting links to cytoskeletal association[1][3]. PTPN4 interacts with subunits of glutamate receptors and is believed to modulate synaptic and cytoskeletal signaling through tyrosine dephosphorylation[1]. Genetic and functional studies suggest PTPN4 and related PTPs are essential for normal cellular homeostasis, and their dysregulation is involved in the onset of diseases such as cancer[2][4]. Structural analysis reveals diversity among phosphatases relevant for inhibitor design, but PTPN4-specific drug development is still at a preclinical stage[3].
Potential mechanisms center on inhibition of enzymatic activity by small molecules (e.g., targeting the active site) Modulation of substrate or secondary binding pockets, as revealed by structural studies[3][2]
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Tyrosine-protein phosphatase non-receptor type 4 (PTPN4).